Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Hisse Senetlerindeki Sıralama #29904
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Hisse Fiyatı
$1.10
Son senkronizasyon: 2023-06-07
Piyasa Değeri
$19.12M
Değişim (1 gün)
-0.90%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

B piyasa değeri ile STSA fiyatı
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
STSA
$1.10
Piyasa Değeri Satsuma Pharmaceuticals, Inc.(STSA)
Piyasa Değeri: $19.12M
August 2026 itibarıyla Satsuma Pharmaceuticals, Inc. şirketinin piyasa değeri $19.12M. Bu, verilerimize göre Satsuma Pharmaceuticals, Inc. şirketini dünyanın en değerli 29904th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Satsuma Pharmaceuticals, Inc. piyasa değeri geçmişi (2019 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında STSA
STSA’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$305,274 $19.12M
$5.307T +27,752,060.77%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$261,792 $19.12M
$4.551T +23,799,151.07%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$238,990 $19.12M
$4.154T +21,726,238.19%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$206,440 $19.12M
$3.589T +18,767,150.37%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$160,895 $19.12M
$2.797T +14,626,747.68%